Varicella zoster virus transmission in the vaccine era: Unmasking the role of herpes zoster

Journal of Infectious Diseases

Volumn 205, Issue 9, 2012, Pages 1331-1333

  Bloch, Karen C ^a,b   Johnson, James G ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE IMMUNIZATION; CHICKENPOX; CONTACT EXAMINATION; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SURVEILLANCE; HERPES ZOSTER; HUMAN; INFECTION CONTROL; INFECTION RISK; PRIORITY JOURNAL; REVIEW; SECONDARY INFECTION; VIRUS LOAD; VIRUS REACTIVATION; VIRUS SHEDDING; VIRUS TRANSMISSION;

CHICKENPOX; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS;

EID: 84861568340     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis214     Document Type: Review

References (30)

1. Centers for Disease Control and Prevention. Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-40.
2. Guris D, Jumaan A, Mascola L, et al. Changing varicella epidemiology in active surveillance sites-United States, 1995-2005. J Infect Dis 2008; 197:S71-5.
3. Centers for Disease Control and Prevention. Public health response to varicella outbreaks-United States, 2003-2004. MMWR Morb Mortal Wkly Rep 2006; 55:993-5.
4. Viner K, Perella D, Lopez A, et al. Transmission of varicella zoster virus from herpes zoster and varicella cases in school and daycare settings. J Infect Dis 2012; 205: 1336-41.
5. Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics 2006; 117:e1070-7.
6. Centers for Disease Control and Prevention. Outbreak of varicella among vaccinated children-Michigan, 2003. MMWR Morb Mortal Wkly Rep 2004; 53:389-92.
7. Miron D, Lavi I, Kitov R, Hendler A. Vaccine effectiveness and severity of varicella among previously vaccinated children during outbreaks in day-care centers with low vaccination coverage. Pediatr Infect Dis J 2005; 24:233-6.
8. Gould PL, Leung J, Scott C, et al. An outbreak of varicella in elementary school children with two-dose varicella vaccine recipients-Arkansas, 2006. Pediatr Infect Dis J 2009; 28:678-81.
9. Nguyen MD, Perella D, Watson B, Marin M, Renwick M, Spain CV. Incremental effectiveness of second dose varicella vaccination for outbreak control at an elementary school in Philadelphia, Pennsylvania, 2006. Pediatr Infect Dis J 2010; 29:685-9.
10. Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics 2008; 122:e744-50.
11. Hambleton S, Gershon AA. The impact of varicella vaccination in the United States. Semin Pediatr Infect Dis 2005; 16:38-43.
12. Watson BM, Piercy SA, Plotkin SA, Starr SE. Modified chickenpox in children immunized with the Oka/Merck varicella vaccine. Pediatrics 1993; 91:17-22.
13. Chaves SS, Zhang J, Civen R, et al. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005. J Infect Dis 2008; 197:S127-31.
14. Shapiro ED, Vazquez M, Esposito D, et al. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis 2011; 203: 312-15.
15. Reynolds MA, Chaves SS, Harpaz R, Lopez AS, Seward JF. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review. J Infect Dis 2008; 197:S224-7.
16. Leung J, Harpaz R, Molinari NA, Jumaan A, Zhou F. Herpes zoster incidence among insured persons in the United States 1993-2006: evaluation of impact of varicella vaccination. Clin Infect Dis 2011; 52: 332-40.
17. Brisson M, Gay NJ, Edmunds WJ, Andrews NJ. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine 2002; 20:2500-7.
18. Wootton SH, Law B, Tan B, Mozel M, Scheifele DW, Halperin S. The epidemiology of children hospitalized with herpes zoster in Canada: immunization Monitoring Program, Active (IMPACT), 1991-2005. Pediatr Infect Dis J 2008; 27: 112-17.
19. Sharrar RG, LaRussa P, Galea SA. The postmarketing safety profile of varicella vaccine. Vaccine 2001; 19:916-23.
20. Seiler HE. A study of herpes zoster particularly in its relationship to chickenpox. J Hyg (Lond) 1949; 47:253-62.
21. Lopez AS, Marin M. Strategies for the control and investigation of varicella outbreaks 2008. http://www.cdc.gov/chickenpox/outbreaks/manual.html. Accessed 7 December 2011.
22. Sawyer MH, Chamberlin CJ, Wu YN, Aintablian N, Wallace MR. Detection of varicella-zoster virus DNA in air samples from hospital rooms. J Infect Dis 1994; 169: 91-4.
23. Suzuki K, Yoshikawa T, Tomitaka A, Matsunaga K, Asano Y. Detection of aerosolized varicella-zoster virus DNA in patients with localized herpes zoster. J Infect Dis 2004; 189:1009-12.
24. Johnson JA, Bloch KC, Dang BN. Varicella reinfection in a seropositive physician following occupational exposure to localized zoster. Clin Infect Dis 2011; 52:907-9.
25. Cholongitas E, Ilonidis G. Transmission of varicella-zoster virus originating from a patient with localized herpes zoster: implications for infection control? Am J Infect Control 2010; 38:669-70.
26. Nagel MA, Choe A, Cohrs RJ, et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J Infect Dis 2011; 204: 820-4.
27. Quinlivan ML, Ayres KL, Kelly PJ, et al. Persistence of varicella-zoster virus viraemia in patients with herpes zoster. J Clin Virol 2011; 50:130-5.
28. Walther BA, Ewald PW. Pathogen survival in the external environment and the evolution of virulence. Biol Rev Camb Philos Soc 2004; 79:849-69.
29. Siegel JD, Rhinehart E, Jackson M, Chiarello L. 2007 guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control 2007; 35:S65-164.
30. Schmid DS, Jumaan AO. Impact of varicella vaccine on varicella-zoster dynamics. Clin Microbiol Rev 2010; 23:202-17.